Skip to main content
. 2012 Dec 27;12:377. doi: 10.1186/1471-2334-12-377

Table 3.

Incidence of adverse events that caused discontinuation of treatment

Adverse events (n = 40) Incidence of occurrence, n (%)
Laboratory abnormality
16 (40)
Descompensated cirrhosis (ascites/encephalopathy)
7 (17.5)
Incapacitating symptoms
4 (10)
Acute Renal Failure
3 (7.5)
Psoriasis
1 (2.5)
Diagnosis of Hepatocellular carcinoma
1 (2.5)
Death 8 (20)